Total number of protein in "GO:0060326" GO term: 73
| Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCC1-202 | ABCC1 | P33527 | Multidrug resistance-associated protein 1 | chr16 | GO:0060326 | Not Cancer Driver | No | 157 | 0.1025473546701502 | 123 | 18 | 0.0117570215545395 | 1 |
| ACKR2-201 | ACKR2 | O00590 | Atypical chemokine receptor 2 | chr3 | GO:0060326 | Not Cancer Driver | No | 51 | 0.1328125 | 25 | 4 | 0.0104166666666666 | 0 |
| ACKR3-201 | ACKR3 | P25106 | Atypical chemokine receptor 3 | chr2 | GO:0060326 | Census, Compendium | Yes | 54 | 0.149171270718232 | 0 | 0 | 0.0 | 1 |
| ACKR4-201 | ACKR4 | Q9NPB9 | Atypical chemokine receptor 4 | chr3 | GO:0060326 | Not Cancer Driver | No | 34 | 0.0971428571428571 | 11 | 0 | 0.0 | 0 |
| AGTR1-201 | AGTR1 | P30556 | Type-1 angiotensin II receptor | chr3 | GO:0060326 | Not Cancer Driver | No | 70 | 0.1949860724233983 | 0 | 0 | 0.0 | 1 |
| ARHGEF16-203 | ARHGEF16 | Q5VV41 | Rho guanine nucleotide exchange factor 16 | chr1 | GO:0060326 | Not Cancer Driver | No | 55 | 0.077574047954866 | 299 | 10 | 0.0141043723554301 | 0 |
| ARRB2-201 | ARRB2 | P32121 | Beta-arrestin-2 | chr17 | GO:0060326 | Not Cancer Driver | No | 39 | 0.0953545232273838 | 122 | 19 | 0.0464547677261613 | 0 |
| AZU1-201 | AZU1 | P20160 | Azurocidin | chr19 | GO:0060326 | Not Cancer Driver | No | 34 | 0.1354581673306772 | 53 | 7 | 0.0278884462151394 | 0 |
| BCAR1-201 | BCAR1 | P56945 | Breast cancer anti-estrogen resistance protein 1 | chr16 | GO:0060326 | Not Cancer Driver | No | 88 | 0.1011494252873563 | 681 | 64 | 0.0735632183908046 | 0 |
| BIN2-210 | BIN2 | Q9UBW5 | Bridging integrator 2 | chr12 | GO:0060326 | Not Cancer Driver | No | 63 | 0.111504424778761 | 358 | 38 | 0.0672566371681415 | 0 |
| C5-201 | C5 | P01031 | Complement C5 | chr9 | GO:0060326 | Not Cancer Driver | No | 124 | 0.0739856801909307 | 86 | 6 | 0.0035799522673031 | 0 |
| CCL20-201 | CCL20 | P78556 | C-C motif chemokine 20 | chr2 | GO:0060326 | Not Cancer Driver | No | 15 | 0.15625 | 0 | 0 | 0.0 | 0 |
| CCL21-201 | CCL21 | O00585 | C-C motif chemokine 21 | chr9 | GO:0060326 | Not Cancer Driver | No | 12 | 0.0895522388059701 | 59 | 5 | 0.0373134328358208 | 0 |
| CCL25-202 | CCL25 | O15444 | C-C motif chemokine 25 | chr19 | GO:0060326 | Not Cancer Driver | No | 16 | 0.1066666666666666 | 27 | 3 | 0.02 | 0 |
| CCL27-201 | CCL27 | Q9Y4X3 | C-C motif chemokine 27 | chr9 | GO:0060326 | Not Cancer Driver | No | 8 | 0.0714285714285714 | 0 | 0 | 0.0 | 0 |
| CCL28-201 | CCL28 | Q9NRJ3 | C-C motif chemokine 28 | chr5 | GO:0060326 | Not Cancer Driver | No | 11 | 0.0866141732283464 | 48 | 7 | 0.0551181102362204 | 0 |
| CCN3-201 | CCN3 | P48745 | CCN family member 3 | chr8 | GO:0060326 | Not Cancer Driver | No | 49 | 0.1372549019607843 | 20 | 2 | 0.0056022408963585 | 0 |
| CCR1-201 | CCR1 | P32246 | C-C chemokine receptor type 1 | chr3 | GO:0060326 | Not Cancer Driver | No | 47 | 0.1323943661971831 | 14 | 0 | 0.0 | 0 |
| CCR10-201 | CCR10 | P46092 | C-C chemokine receptor type 10 | chr17 | GO:0060326 | Not Cancer Driver | No | 33 | 0.0911602209944751 | 41 | 12 | 0.0331491712707182 | 0 |
| CCR2-201 | CCR2 | P41597 | C-C chemokine receptor type 2 | chr3 | GO:0060326 | Not Cancer Driver | No | 56 | 0.1497326203208556 | 23 | 2 | 0.0053475935828877 | 0 |
| CCR3-202 | CCR3 | P51677 | C-C chemokine receptor type 3 | chr3 | GO:0060326 | Not Cancer Driver | No | 66 | 0.1859154929577464 | 0 | 0 | 0.0 | 0 |
| CCR4-201 | CCR4 | P51679 | C-C chemokine receptor type 4 | chr3 | GO:0060326 | Census | Yes | 34 | 0.0944444444444444 | 0 | 0 | 0.0 | 0 |
| CCR5-201 | CCR5 | P51681 | C-C chemokine receptor type 5 | chr3 | GO:0060326 | Not Cancer Driver | No | 34 | 0.096590909090909 | 0 | 0 | 0.0 | 0 |
| CCR6-201 | CCR6 | P51684 | C-C chemokine receptor type 6 | chr6 | GO:0060326 | Not Cancer Driver | No | 46 | 0.1229946524064171 | 13 | 2 | 0.0053475935828877 | 0 |
| CCR7-201 | CCR7 | P32248 | C-C chemokine receptor type 7 | chr17 | GO:0060326 | Census, Compendium | Yes | 42 | 0.1111111111111111 | 0 | 0 | 0.0 | 0 |
| CCR8-201 | CCR8 | P51685 | C-C chemokine receptor type 8 | chr3 | GO:0060326 | Not Cancer Driver | No | 45 | 0.1267605633802817 | 3 | 0 | 0.0 | 0 |
| CCR9-201 | CCR9 | P51686 | C-C chemokine receptor type 9 | chr3 | GO:0060326 | Not Cancer Driver | No | 44 | 0.1192411924119241 | 0 | 0 | 0.0 | 0 |
| CCRL2-202 | CCRL2 | O00421 | C-C chemokine receptor-like 2 | chr3 | GO:0060326 | Not Cancer Driver | No | 26 | 0.0755813953488372 | 21 | 1 | 0.002906976744186 | 0 |
| CRK-201 | CRK | P46108 | Adapter molecule crk | chr17 | GO:0060326 | Not Cancer Driver | No | 24 | 0.0789473684210526 | 197 | 19 | 0.0625 | 0 |
| CRKL-201 | CRKL | P46109 | Crk-like protein | chr22 | GO:0060326 | Not Cancer Driver | No | 24 | 0.0792079207920792 | 160 | 17 | 0.0561056105610561 | 0 |
| CX3CL1-201 | CX3CL1 | P78423 | Fractalkine | chr16 | GO:0060326 | Not Cancer Driver | No | 53 | 0.1335012594458438 | 259 | 36 | 0.0906801007556675 | 0 |
| CX3CR1-202 | CX3CR1 | P49238 | CX3C chemokine receptor 1 | chr3 | GO:0060326 | Not Cancer Driver | No | 60 | 0.1690140845070422 | 0 | 0 | 0.0 | 0 |
| CXCL12-203 | CXCL12 | P48061 | Stromal cell-derived factor 1 | chr10 | GO:0060326 | Not Cancer Driver | No | 8 | 0.086021505376344 | 0 | 0 | 0.0 | 0 |
| CXCL14-201 | CXCL14 | O95715 | C-X-C motif chemokine 14 | chr5 | GO:0060326 | Not Cancer Driver | No | 16 | 0.1441441441441441 | 0 | 0 | 0.0 | 0 |
| CXCR3-202 | CXCR3 | P49682 | C-X-C chemokine receptor type 3 | chrX | GO:0060326 | Not Cancer Driver | No | 37 | 0.1005434782608695 | 15 | 0 | 0.0 | 0 |
| CXCR4-201 | CXCR4 | P61073 | C-X-C chemokine receptor type 4 | chr2 | GO:0060326 | Census, Compendium | Yes | 45 | 0.1278409090909091 | 5 | 0 | 0.0 | 0 |
| CXCR5-201 | CXCR5 | P32302 | C-X-C chemokine receptor type 5 | chr11 | GO:0060326 | Not Cancer Driver | No | 28 | 0.075268817204301 | 0 | 0 | 0.0 | 0 |
| CXCR6-201 | CXCR6 | O00574 | C-X-C chemokine receptor type 6 | chr3 | GO:0060326 | Not Cancer Driver | No | 30 | 0.087719298245614 | 0 | 0 | 0.0 | 0 |
| DEFB103A-201 | DEFB103B | P81534 | Beta-defensin 103 | chr8 | GO:0060326 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| DEFB103B-201 | DEFB103B | P81534 | Beta-defensin 103 | chr8 | GO:0060326 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| DEFB109B-201 | DEFB109B | Q30KR1 | Putative beta-defensin 109B | chr8 | GO:0060326 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| DEFB110-201 | DEFB110 | Q30KQ9 | Beta-defensin 110 | chr6 | GO:0060326 | Not Cancer Driver | No | 22 | 0.3283582089552239 | 0 | 0 | 0.0 | 0 |
| DEFB114-201 | DEFB114 | Q30KQ6 | Beta-defensin 114 | chr6 | GO:0060326 | Not Cancer Driver | No | 23 | 0.3333333333333333 | 0 | 0 | 0.0 | 0 |
| DEFB130A-201 | DEFB130A | P0DP74 | Beta-defensin 130A | chr8 | GO:0060326 | Not Cancer Driver | No | 0 | 0.0 | 5 | 0 | 0.0 | 0 |
| DEFB130B-201 | DEFB130A | P0DP74 | Beta-defensin 130A | chr8 | GO:0060326 | Not Cancer Driver | No | 0 | 0.0 | 5 | 0 | 0.0 | 0 |
| DEFB4A-201 | DEFB4B | O15263 | Defensin beta 4A | chr8 | GO:0060326 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| DEFB4B-201 | DEFB4B | O15263 | Defensin beta 4A | chr8 | GO:0060326 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| DOCK4-206 | DOCK4 | Q8N1I0 | Dedicator of cytokinesis protein 4 | chr7 | GO:0060326 | Not Cancer Driver | No | 258 | 0.1312309257375381 | 398 | 67 | 0.0340793489318413 | 0 |
| ELMO2-201 | ELMO2 | Q96JJ3 | Engulfment and cell motility protein 2 | chr20 | GO:0060326 | Not Cancer Driver | No | 69 | 0.0958333333333333 | 102 | 11 | 0.0152777777777777 | 0 |
| EPHA2-201 | EPHA2 | P29317 | Ephrin type-A receptor 2 | chr1 | GO:0060326 | Compendium | Yes | 147 | 0.1506147540983606 | 188 | 33 | 0.033811475409836 | 3 |
| EPHB1-201 | EPHB1 | P54762 | Ephrin type-B receptor 1 | chr3 | GO:0060326 | Not Cancer Driver | No | 260 | 0.2642276422764227 | 67 | 14 | 0.0142276422764227 | 0 |
| HBEGF-201 | HBEGF | Q99075 | Proheparin-binding EGF-like growth factor | chr5 | GO:0060326 | Not Cancer Driver | No | 11 | 0.0528846153846153 | 63 | 2 | 0.0096153846153846 | 0 |
| HGF-201 | HGF | P14210 | Hepatocyte growth factor | chr7 | GO:0060326 | Compendium | Yes | 196 | 0.2692307692307692 | 43 | 16 | 0.0219780219780219 | 0 |
| HMGB2-201 | HMGB2 | P26583 | High mobility group protein B2 | chr4 | GO:0060326 | Not Cancer Driver | No | 26 | 0.124401913875598 | 207 | 26 | 0.124401913875598 | 0 |
| HOXB9-201 | HOXB9 | P17482 | Homeobox protein Hox-B9 | chr17 | GO:0060326 | Not Cancer Driver | No | 23 | 0.092 | 191 | 22 | 0.088 | 0 |
| KIT-201 | KIT | P10721 | Mast/stem cell growth factor receptor Kit | chr4 | GO:0060326 | Census, Compendium | Yes | 186 | 0.1905737704918032 | 84 | 24 | 0.0245901639344262 | 15 |
| LEF1-201 | LEF1 | Q9UJU2 | Lymphoid enhancer-binding factor 1 | chr4 | GO:0060326 | Census | Yes | 51 | 0.1278195488721804 | 372 | 47 | 0.1177944862155388 | 0 |
| LOX-201 | LOX | P28300 | Protein-lysine 6-oxidase | chr5 | GO:0060326 | Compendium | Yes | 31 | 0.0743405275779376 | 172 | 8 | 0.0191846522781774 | 4 |
| LPAR1-205 | LPAR1 | Q92633 | Lysophosphatidic acid receptor 1 | chr9 | GO:0060326 | Not Cancer Driver | No | 55 | 0.1510989010989011 | 21 | 5 | 0.0137362637362637 | 0 |
| PDGFB-201 | PDGFB | P01127 | Platelet-derived growth factor subunit B | chr22 | GO:0060326 | Census | Yes | 30 | 0.1244813278008298 | 99 | 16 | 0.0663900414937759 | 2 |
| PDGFRA-201 | PDGFRA | P16234 | Platelet-derived growth factor receptor alpha | chr4 | GO:0060326 | Census, Compendium | Yes | 213 | 0.1955922865013774 | 173 | 36 | 0.0330578512396694 | 2 |
| PDGFRB-201 | PDGFRB | P09619 | Platelet-derived growth factor receptor beta | chr5 | GO:0060326 | Census, Compendium | Yes | 134 | 0.1211573236889692 | 233 | 40 | 0.0361663652802893 | 7 |
| PIP5K1A-202 | PIP5K1A | Q99755 | Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | chr1 | GO:0060326 | Not Cancer Driver | No | 53 | 0.094306049822064 | 217 | 22 | 0.0391459074733096 | 0 |
| PLXNB3-201 | PLXNB3 | Q9ULL4 | Plexin-B3 | chrX | GO:0060326 | Not Cancer Driver | No | 168 | 0.0880041906757464 | 358 | 30 | 0.0157150340492404 | 0 |
| PRKCD-201 | PRKCD | Q05655 | Protein kinase C delta type | chr3 | GO:0060326 | Compendium | Yes | 52 | 0.0769230769230769 | 43 | 7 | 0.0103550295857988 | 0 |
| PRKCQ-201 | PRKCQ | Q04759 | Protein kinase C theta type | chr10 | GO:0060326 | Not Cancer Driver | No | 124 | 0.1756373937677053 | 28 | 8 | 0.0113314447592068 | 0 |
| RAC1-201 | RAC1 | P63000 | Ras-related C3 botulinum toxin substrate 1 | chr7 | GO:0060326 | Census, Compendium | Yes | 61 | 0.3177083333333333 | 2 | 0 | 0.0 | 6 |
| RAC3-201 | RAC3 | P60763 | Ras-related C3 botulinum toxin substrate 3 | chr17 | GO:0060326 | Not Cancer Driver | No | 20 | 0.1041666666666666 | 0 | 0 | 0.0 | 4 |
| RHOG-201 | RHOG | P84095 | Rho-related GTP-binding protein RhoG | chr11 | GO:0060326 | Not Cancer Driver | No | 20 | 0.1047120418848167 | 22 | 3 | 0.0157068062827225 | 0 |
| SEMA5A-201 | SEMA5A | Q13591 | Semaphorin-5A | chr5 | GO:0060326 | Not Cancer Driver | No | 221 | 0.2057728119180633 | 24 | 2 | 0.0018621973929236 | 0 |
| TPBG-201 | TPBG | Q13641 | Trophoblast glycoprotein | chr6 | GO:0060326 | Not Cancer Driver | No | 39 | 0.0928571428571428 | 13 | 1 | 0.0023809523809523 | 0 |
| VCAM1-201 | VCAM1 | P19320 | Vascular cell adhesion protein 1 | chr1 | GO:0060326 | Not Cancer Driver | No | 152 | 0.2056833558863328 | 110 | 21 | 0.0284167794316644 | 0 |
| XCR1-201 | XCR1 | P46094 | Chemokine XC receptor 1 | chr3 | GO:0060326 | Not Cancer Driver | No | 52 | 0.1561561561561561 | 1 | 0 | 0.0 | 0 |